Laboratory Biosafety Guidance Related to the Novel Coronavirus (2019-nCoV) | NLM

Disaster Information Management Research Center | NLM

Laboratory Biosafety Guidance Related to the Novel Coronavirus (2019-nCoV)

02/12/2020 12:00 AM EST

Source: World Health Organization (WHO). Published: 2/12/2020. The purpose of this 12-page document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients that meet the case definition of the novel pathogen identified in Wuhan, China, i.e., 2019 novel coronavirus (2019-nCoV), the disease named COVID-19. It also includes the packaging and shipment requirements for sending specimens to World Health Organization-appointed 2019-nCoV referral laboratories. (PDF)